Key acquisition to spur post-pandemic gains

Baxter’s shares are down about 15% since hitting $92 in April 2020. That’s largely because hospitals postponed elective surgical procedures due to the COVID-19 pandemic. Now that the pandemic is easing, demand for its products is rebounding. The company’s upcoming purchase of hospital equipment maker… Read More

Earnings rise 24.3% at Baxter International

Earnings rise 24.3% at Baxter International

This firm is seeing improved sales and earnings as hospitals and research labs start to order new equipment now that the COVID-19 pandemic is easing. The company will also benefit from its recent acquisitions. 

Meanwhile, the firm continues to make progress on the multi-year restructuring plan… Read More